The independent testing laboratory and formulation firm Digipath, Inc. has announced that their GroSciences The division has completed the preliminary validation tests of its natural pesticide derived from TERPO + Broadspectrum plants that are waiting to be patented.
This product has the potential to serve a mass market and protect marijuana plants from microorganisms.
Tests have shown that TERPO + Broadspectrum serves as a treatment to eliminate the microbial biological load in hemp and cannabis plants. The microbial biological load and microorganisms are the main contributors in the loss of cannabis plants.
Recent experiments on cannabis flower have shown that TERPO + Broadspectrum from GroSciences is effective in decontaminating cannabis and hemp plants, and ensures that cannabis samples are within the test limits of most states.
The test results show that TERPO + Broadspectrum reduced the CFU / g with up to 91% compared to untreated samples.
According to the scientific director of Digipath Inc., Dr. Cindy Orser, the preliminary validation test successfully treated a sample that had previously failed in a state microbial test.
After treatment with BODY + Broad spectrum, the sample passed the test.
Denkin He said that a product like TERPO + Broadspectrum could treat plant material effectively and help make it a salable product with great potential. He added that they would continue advancing with the development and testing of products to be able to introduce it to the market as soon as possible.